Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2013 Update - New Market Study Published
Cancer Genetics, Inc. (CGI) is a pharmaceutical company. The company offers DNA-based cancer diagnostics products and services. Its products include MatBA, UroGenRA, and FHACT. CGI's MatBA is a mature b-cell neoplasm array used in diagnosis and prognosis of non-Hodgkin lymphomas. The company's UroGenRA is an oligonucleotide array product that is developed to detect genomic copy number alterations with prognostic and diagnostic value in kidney, prostate and bladder cancers. Its FHACT is a FISH-based HPV-associated cancer test. The company provides clinical...
View full press release